FindTrial
Sign In

OCTA-Based non-invasive assessment of retinal immune cells for prognosis in posterior uveitis: a prospective, observational study

OCTA-Based non-invasive assessment of retinal immune cells for prognosis in posterior uveitis: a prospective, observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115394
Enrollment
Unknown
Registered
2025-12-25
Start date
2025-12-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-infectious posterior uveitis

Interventions

The Corticosteroid Group:None
The Immunosuppressant Group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Initial diagnosis of non-infectious posterior uveitis. 2.Negative blood workup for infectious causes. 3.Clear ocular media (OCTA quality score >= 7).

Exclusion criteria

Exclusion criteria: 1.Concomitant retinal diseases (e.g., vascular disease, detachment, diabetic retinopathy). 2.Severe systemic conditions (e.g., chronic renal failure, diabetic ketoacidosis). 3.Poor OCTA image quality. 4.Retinal surgery or laser treatment within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Density of Retinal Macrophage-like Cells (MLCs);Best-Corrected Visual Acuity (BCVA);Complete Remission Rate of Uveitis;—

Countries

China

Contacts

Public ContactManjing Cao

Shanghai General Hospital

371282737@qq.com+86 138 7580 4512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026